- Home
- BNZI vs NRXS Comparison
BNZI vs NRXS Comparison
Compare BNZI & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- NRXS
- Stock Information
- Founded
- BNZI 2016
- NRXS 2011
- Country
- BNZI United States
- NRXS United States
- Employees
- BNZI N/A
- NRXS N/A
- Industry
- BNZI
- NRXS
- Sector
- BNZI
- NRXS
- Exchange
- BNZI Nasdaq
- NRXS Nasdaq
- Market Cap
- BNZI 11.5M
- NRXS 13.0M
- IPO Year
- BNZI N/A
- NRXS 2023
- Fundamental
- Price
- BNZI $3.87
- NRXS $2.77
- Analyst Decision
- BNZI Strong Buy
- NRXS Strong Buy
- Analyst Count
- BNZI 1
- NRXS 1
- Target Price
- BNZI $240.00
- NRXS $7.00
- AVG Volume (30 Days)
- BNZI 288.0K
- NRXS 85.1K
- Earning Date
- BNZI 08-13-2025
- NRXS 08-08-2025
- Dividend Yield
- BNZI N/A
- NRXS N/A
- EPS Growth
- BNZI N/A
- NRXS N/A
- EPS
- BNZI N/A
- NRXS N/A
- Revenue
- BNZI $6,827,490.00
- NRXS $2,934,945.00
- Revenue This Year
- BNZI $337.60
- NRXS $138,883.78
- Revenue Next Year
- BNZI $91.81
- NRXS $118.59
- P/E Ratio
- BNZI N/A
- NRXS N/A
- Revenue Growth
- BNZI 52.95
- NRXS 27.52
- 52 Week Low
- BNZI $3.51
- NRXS $1.33
- 52 Week High
- BNZI $112.00
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- BNZI 31.92
- NRXS 57.38
- Support Level
- BNZI $3.79
- NRXS $2.55
- Resistance Level
- BNZI $4.44
- NRXS $2.92
- Average True Range (ATR)
- BNZI 0.46
- NRXS 0.17
- MACD
- BNZI 0.11
- NRXS 0.03
- Stochastic Oscillator
- BNZI 15.45
- NRXS 78.26
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).